Skip to main content
Infectious Diseases and Therapy logoLink to Infectious Diseases and Therapy
. 2022 Nov 5;11(6):2321. doi: 10.1007/s40121-022-00675-z

Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

Xiao-Shan Zhang 1,2, Yu-Zhen Wang 1,2, Da-Wei Shi 1, Fang-Min Xu 1,2, Jun-Hui Yu 1,2, Jie Chen 3, Guan-Yang Lin 1, Chun-Hong Zhang 1,, Xu-Ben Yu 1,, Cong-Rong Tang 1,
PMCID: PMC9669286  PMID: 36333476

Correction to: Infect Dis Ther 10.1007/s40121-022-00621-z

In the original publication of the article, there should be three corresponding authors;

Chun-Hong Zhang, Xu-Ben Yu and Cong-Rong Tang

This has been corrected in this paper.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Chun-Hong Zhang, Email: zch760217@163.com.

Xu-Ben Yu, Email: yuxuben@126.com.

Cong-Rong Tang, Email: tcrab1@163.com.


Articles from Infectious Diseases and Therapy are provided here courtesy of Springer

RESOURCES